0001209191-24-003544.txt : 20240220
0001209191-24-003544.hdr.sgml : 20240220
20240220164259
ACCESSION NUMBER: 0001209191-24-003544
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burgess Justin
CENTRAL INDEX KEY: 0001812025
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 24654267
MAIL ADDRESS:
STREET 1: C/O DYNAVAX TECHNOLOGIES CORPORATION
STREET 2: 2100 POWELL STREET, SUITE 1900
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-15
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001812025
Burgess Justin
C/O DYNAVAX TECHNOLOGIES
2100 POWELL STREET, SUITE 720
EMERYVILLE
CA
94608
0
1
0
0
Chief Accounting Officer
0
Common Stock
2024-02-16
4
M
0
6667
A
15803
D
Common Stock
2024-02-16
4
F
0
2378
12.41
D
13425
D
Restricted Stock Unit
2024-02-16
4
M
0
6667
D
Common Stock
6667
13333
D
Stock Options (Right to Buy)
12.48
2024-02-15
4
A
0
13500
0.00
A
2031-02-15
Common Stock
13500
13500
D
Restricted Stock Unit
2024-02-15
4
A
0
21900
A
Common Stock
21900
21900
D
Code M: Exercise or conversion of derivative security
Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 16, 2023.
Code F: Payment of exercise price or tax liability by delivering or withholding securities
Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.
Code A: Grant, award or other acquisition
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of
February 15, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual
anniversary of February 15, 2024.
/s/ JUSTIN BURGESS
2024-02-20